The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression
Herni Basir, Annisa Salsabilla Dwi Nugrahani, Andi Makbul Aman, Syakib Bakri, Haerani Rasyid, Husaini Umar, Faridin H. P., Andi Muhammad Ichsan, Andi Alfian Zainuddin · 2024
Read The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression by Herni Basir, Annisa Salsabilla Dwi Nugrahani, Andi Makbul Aman, Syakib Bakri, Haerani Rasyid, Husaini Umar, Faridin H. P., Andi Muhammad Ichsan, Andi Alfian Zainuddin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11648683.txt.
Description
Herni Basir and co-authors pool studies on a hormone-like protein, FGF21, and eye damage in type 2 diabetes. The protein helps control blood sugar, but past studies disagreed on whether high levels raise or lower the risk of diabetic retinopathy. The team searched four databases through May 2024.
Across nearly 6,000 people, higher FGF21 went with more eye disease and more sight-threatening disease. Levels did not differ between plain and severe disease groups. A split by cholesterol level showed a gap in disease rates. The authors propose the protein as a marker to flag patients for eye checks.
Catalog record
| CREATOR | Herni Basir, Annisa Salsabilla Dwi Nugrahani, Andi Makbul Aman, Syakib Bakri, Haerani Rasyid, Husaini Umar, Faridin H. P., Andi Muhammad Ichsan, Andi Alfian Zainuddin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |